Literature DB >> 15482343

Clinical characteristics and outcome of patients with cirrhosis and refractory ascites.

Richard Moreau1, Paul Delègue, Fabienne Pessione, Sophie Hillaire, François Durand, Didier Lebrec, Dominique-Charles Valla.   

Abstract

BACKGROUND: In patients with cirrhosis, refractory ascites is associated with a poor prognosis and is an indication for liver transplantation. However, factors that determine prognosis remain unclear. AIMS: To investigate the predictive factors of prognosis in patients with refractory ascites.
METHODS: Seventy-five patients with refractory ascites were followed-up for 18+/-13 months (mean+/-SD) and survival was analyzed.
RESULTS: The 1-year probability of survival was 52%. Univariate analyses showed that older patients, hepatocellular carcinoma and diabetes, all assessed at entry, were associated with significantly increased risk ratios of death. The risk ratio of death was significantly lower in abstinent alcoholics than in patients with nonalcoholic cirrhosis. The risk ratio of death did not significantly differ between patients with nonalcoholic cirrhosis and nonabstinent alcoholics. Child-Pugh score at entry had no prognostic value. Multivariate analysis showed that older age, hepatocellular carcinoma, diabetes and abstinence were independent prognostic factors.
CONCLUSIONS: In patients with cirrhosis and refractory ascites, older age, hepatocellular carcinoma and diabetes, but not Child-Pugh score at entry, were independent predictive factors of poor survival while abstinence was an independent predictive factor of good survival. These findings should be taken into account when deciding on liver transplantation in patients with refractory ascites.

Entities:  

Mesh:

Year:  2004        PMID: 15482343     DOI: 10.1111/j.1478-3231.2004.0991.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  34 in total

1.  Treatment of refractory ascites.

Authors:  Praveena G Velamati; H Franklin Herlong
Journal:  Curr Treat Options Gastroenterol       Date:  2006

2.  Impact of diabetes on the risk of serious liver events and liver-related deaths in people living with HIV and hepatitis C co-infection: data from the ICONA Foundation Cohort Study.

Authors:  Sebastiano Leone; Patrizia Lorenzini; Alessandro Cozzi-Lepri; Giancarlo Orofino; Dario Bernacchia; Antonella Castagna; Marianna Menozzi; Giovanni Guaraldi; Giordano Madeddu; Antonio Di Biagio; Massimo Puoti; Andrea Gori; Antonella d'Arminio Monforte
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-06-22       Impact factor: 3.267

Review 3.  Implications of Nonalcoholic Steatohepatitis as the Cause of End-Stage Liver Disease Before and After Liver Transplant.

Authors:  Anchalia Chandrakumaran; Mohammad Shadab Siddiqui
Journal:  Gastroenterol Clin North Am       Date:  2020-03       Impact factor: 3.806

Review 4.  Management of ascites and hepatorenal syndrome.

Authors:  Salvatore Piano; Marta Tonon; Paolo Angeli
Journal:  Hepatol Int       Date:  2017-08-23       Impact factor: 6.047

5.  Diagnosis and therapy of ascites in liver cirrhosis.

Authors:  Erwin Biecker
Journal:  World J Gastroenterol       Date:  2011-03-14       Impact factor: 5.742

6.  Managing complications in cirrhotic patients.

Authors:  Markus Peck-Radosavljevic; Paolo Angeli; Juan Cordoba; Oliver Farges; Dominique Valla
Journal:  United European Gastroenterol J       Date:  2015-02       Impact factor: 4.623

7.  Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial.

Authors:  Yoshiyuki Narahara; Hidenori Kanazawa; Takeshi Fukuda; Yoko Matsushita; Hirotomo Harimoto; Hideko Kidokoro; Tamaki Katakura; Masanori Atsukawa; Yasuhiko Taki; Yuu Kimura; Katsuhisa Nakatsuka; Choitsu Sakamoto
Journal:  J Gastroenterol       Date:  2010-07-15       Impact factor: 7.527

Review 8.  Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management.

Authors:  Diego Garcia-Compean; Joel Omar Jaquez-Quintana; Jose Alberto Gonzalez-Gonzalez; Hector Maldonado-Garza
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

9.  Liver transplantation in adults: Choosing the appropriate timing.

Authors:  Maria Siciliano; Lucia Parlati; Federica Maldarelli; Massimo Rossi; Stefano Ginanni Corradini
Journal:  World J Gastrointest Pharmacol Ther       Date:  2012-08-06

10.  Automated low flow pump system for the treatment of refractory ascites: a single-center experience.

Authors:  M N Thomas; G H Sauter; A L Gerbes; M Stangl; T S Schiergens; M Angele; J Werner; M Guba
Journal:  Langenbecks Arch Surg       Date:  2015-11-13       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.